FarsheedAbdul-Rahman

Associate

Dubai + 971.4.709.8410

Connect:

Share

Farsheed Abdul-Rahman advises on corporate, regulatory, commercial, and M&A transactions. Farsheed has acted on a range of acquisitions, disposals, and joint ventures. He has extensive experience advising on corporate governance issues, complex commercial relationships, employment, health care, data protection, and corporate structuring and reorganizations in the United Arab Emirates (UAE), the Kingdom of Saudi Arabia, and the wider Middle East.

Farsheed started his career at an international law firm in London and also served a secondment with the legal team at one of Europe's leading energy companies. Prior to joining Jones Day, Farsheed practiced at one of the largest law firms in the UAE. Farsheed regularly works with local and federal authorities in the UAE and has built extensive knowledge of the UAE's corporate, commercial, and regulatory framework.

Farsheed regularly contributes to publications for the World Bank and Transparency International. He is coauthor of the official commentary to the Companies Law of the Dubai International Financial Centre (published by Lexis Nexis). Farsheed has been recognized by Chambers & Partners as being "very responsive" and proficient at providing "commercial as well as legal advice."

Experience

  • WEG acquires industrial electric motors and generators business from Regal Rexnord CorporationJones Day advised WEG S.A. in the $400 million acquisition of the industrial electric motors and generators business of Regal Rexnord Corporation.
  • Valmet acquires process gas chromatography business of Siemens AGJones Day advised Valmet Oyj in the €102.5 million acquisition of the process gas chromatography business of Siemens AG.
  • Mayo Clinic sells stake in Sheikh Shakhbout Medical CityJones Day advised Mayo Clinic on matters of UAE law in relation to the sale of its 25% interest in Sheikh Shakhbout Medical City (SSMC) to Abu Dhabi Health Services Company (SEHA).
  • Mapei acquires BitumatJones Day advised Mapei, a multinational group leader in the manufacture of chemical products for the building industry, in its acquisition of Bitumat, a leading company in the manufacture and marketing of waterproofing systems based Saudi Arabia, with operations across the GCC.
  • NEP Group sells SOS Global to Rock-it CargoJones Day advised NEP Group in its sale of SOS Global (SOS) to Rock-it Cargo, the global leader in end-to-end logistics for live events and high net worth goods.
  • ABS sells technical inspection service line to ApaveJones Day advised ABS Group of Companies, Inc. in the sale by one of its subsidiaries, ABSG Consulting, Inc., of its technical inspection service line to Apave Group, an international inspection group.
  • Leading unicorn digital asset company cooperates on JV in UAEJones Day represented a leading unicorn digital asset company on its cooperation and JV arrangements with a leading asset management firm in the UAE. The JV involved market entry arrangements into the UAE and GCC markets.
  • SAP forms strategic partnership with Dediq for financial services industriesJones Day advised SAP in the formation of SAP Fioneer, a joint venture with the Munich based investor DEDIQ GmbH whereby SAP contributed its Financial Services and Insurance Services business and DEDIQ will invest more than €500 million.
  • Cardinal Health sells its Cordis business to Hellman & Friedman for approximately $1 billionJones Day advised Cardinal Health in connection with the divestiture of its Cordis business to Hellman & Friedman for approximately $1 billion.
  • Signature Aviation sells Global Engine Services business to StandardAero for $230 millionJones Day advised Signature Aviation plc, a market-leading provider of global aviation support services, in the $230 million sale of the Engine Repair and Overhaul (ERO) business to StandardAero, a portfolio company owned by The Carlyle Group and a leading provider of maintenance, repair, and overhaul services.
  • STERIS acquires Cantel Medical for $3.6 billionJones Day advised STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • American Industrial Partners acquires High Pressure Solutions Segment of Ingersoll Rand for $300 millionJones Day advised American Industrial Partners in its $300 million acquisition of a majority interest in the High Pressure Solutions Segment of Ingersoll Rand, a premier market leader in the manufacturing, service, and repair of high-pressure pumps and related consumables in the upstream energy market.
  • Twilio acquires ValueFirstJones Day advised Twilio Inc. in its acquisition of ValueFirst Digital Media Private Limited, a leading Indian provider of digital communication solutions through telephone voice and data communications offering services in India and South-East Asia.
  • Seal for Life acquires CanusaJones Day advised Arsenal Capital Partners in the acquisition by portfolio company, Seal For Life Industries, of the Canusa-CPS and Dhatec businesses from Shawcor.
  • Allrise Capital leads Series A investment in IntellectoKidsJones Day represented Allrise Capital in its lead Series A investment in IntellectoKids, a rapidly growing provider of online educational solutions for kids.
  • PolyOne acquires Clariant color and additive masterbatch business for $1.5 billionJones Day advised PolyOne Corporation in the $1.5 billion purchase of Clariant’s global color and additive masterbatch business.
  • J.F. Lehman acquires Integrated Global ServicesJones Day advised long-standing client J.F. Lehman & Company, a leading middle-market private equity firm focused exclusively on the aerospace, defense, maritime, government, and environmental sectors, in the acquisition and related financing of Integrated Global Services, Inc. ("IGS").
  • PETRONAS Chemicals acquires Da Vinci Group B.V. for €163 millionJones Day advised PETRONAS Chemicals Group Berhad (PCG) in its acquisition of a 100% stake in Da Vinci Group B.V. from its shareholders including funds managed by Bencis Capital Partners for €163 million.
  • UPL acquires Arysta LifeScience from Platform Specialty Products Corporation for $4.2 billionJones Day advised UPL Limited ("UPL"), a leading global generic agrochemical company based in India, in connection with its subsidiary, UPL Corporation Limited’s, US$4.2 billion acquisition and related $3 billion term financing of Arysta Lifescience Inc. (“Arysta”), a global provider of crop protection solutions, including bio-solutions and seed treatment, from NYSE listed Platform Specialty Products Corporation (“Platform”).
    • View All

    March 2022 Newsletters

    Vital Signs: Digital Health Law Update | Winter 2022

    August 2021 Newsletters

    Vital Signs: Digital Health Law Update | Summer 2021

    April 2021 Newsletters

    Vital Signs: Digital Health Law Update | Spring 2021

    January 2021 Newsletters

    Vital Signs: Digital Health Law Update | Winter 2021

    October 2020 Newsletters

    Vital Signs: Digital Health Law Update | Fall 2020

    July 2020 Newsletters

    Vital Signs: Digital Health Law Update | Summer 2020

    April 2020 Newsletters

    Vital Signs: Digital Health Law Update | Spring 2020

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.